ECHO (EchoStar Corporation) — AI Stock Research
Research of November 3, 2026 · Communication Services / Communications Services, NEC
TradeFlare's AI research teams rate ECHO a HOLD. The latest price is $101.94.
The research plan
- Entry: $101.94
- Time horizon: days
The current market regime and the stock's technical and fundamental profile do not support a buy decision at this time.
Why
The current market regime and the stock's technical and fundamental profile do not support a buy decision at this time. Catalysts to watch: The company's significant cash reserves could be used for strategic initiatives or debt reduction; A potential shift in market sentiment could lead to a re-evaluation of the stock; Any positive news regarding operational improvements or new revenue streams could alter the fundamental outlook. Key risks: Declining revenue and persistent negative profitability indicate significant underlying business challenges; High debt levels and weak interest coverage create financial fragility; Elevated short interest suggests strong market skepticism and potential for further downside.
What could push ECHO higher
- The company's significant cash reserves could be used for strategic initiatives or debt reduction.
- A potential shift in market sentiment could lead to a re-evaluation of the stock.
- Any positive news regarding operational improvements or new revenue streams could alter the fundamental outlook.
Key risks for ECHO
- Declining revenue and persistent negative profitability indicate significant underlying business challenges.
- High debt levels and weak interest coverage create financial fragility.
- Elevated short interest suggests strong market skepticism and potential for further downside.
What each AI research team found
Fundamental team: Bearish · valuation: overvalued
EchoStar presents a bearish fundamental outlook due to declining revenues, persistent unprofitability, and weak financial health metrics, including negative cash flows and critically low interest coverage. Despite a strong analyst buy consensus, the current valuation appears overvalued given these significant operational and financial challenges.
- EchoStar is experiencing a concerning trend of declining revenue (-4% YoY) and persistent negative profitability (Net Margin -38.71%, ROE -33.43%).
- The company's financial health is precarious with negative operating and free cash flow on a TTM basis, and critically low interest coverage (0.51x TTM).
- Despite substantial cash reserves ($13.44 billion), the high debt-to-equity ratio (1.24x) and significant total debt ($17.58 billion) pose considerable risk, especially with upcoming debt maturities.
Technical team: Neutral
The stock is in a neutral sideways trend, trading near resistance with conflicting signals. While bullish patterns are emerging, bearish short-term trend indicators and a lack of strong volume conviction suggest caution, favoring a short-term neutral to slightly bearish outlook until a clear directional move is confirmed.
- Price is consolidating near resistance with bearish moving averages, suggesting a potential short-term pullback towards support.
- The stock is trading in a sideways range with declining volume, suggesting a neutral outlook until a clear breakout or breakdown occurs.
- The price is consolidating near resistance with mixed signals from indicators, suggesting a neutral outlook with potential for a short-term pullback.
Sentiment team: Bullish
The overwhelming positive sentiment from professional analysts, driven by strong buy ratings and the strategic value of its SpaceX stake, outweighs the neutral news and social media sentiment. While there are concerns about revenue contraction and overvaluation, the analyst conviction suggests a bullish outlook with potential for upside.
- EchoStar's news coverage is predominantly neutral with a slight positive average headline score of 0.021, indicating a lack of strong directional sentiment. The next earnings date is November 3, 2026. One headline suggests the stock is overvalued, but...
- EchoStar's social media sentiment is neutral, with a slight positive score of 0.021 driven by a single 'buy' mention, but tempered by an 'overvalued' assessment and a general lack of strong directional discussion. (Score: 0.021)
- EchoStar exhibits strong positive sentiment driven by a unanimous analyst 'Strong Buy' consensus, significant price target upside, and strategic value from its SpaceX stake, despite some revenue headwinds and a slight dip in institutional ownership....
Risk team: High
ECHO presents a HIGH risk profile due to persistent negative cash flows, weak interest coverage, and significant short interest, all exacerbated by high volatility and a deep historical drawdown. The current price of $0.00 and the scanner context of a massive EPS beat on a future date suggest a highly speculative situation with extreme uncertainty, warranting a very small position size and aggressive risk management.
- Negative Operating Cash Flow and Free Cash Flow: The company is consistently generating negative operating and free cash flow, indicating a fundamental inability to fund operations from its core business and a significant risk of financial distress.
- Weak Interest Coverage: With an interest coverage proxy of 0.51, the company's operating income is insufficient to cover its interest expenses, posing a substantial risk of default on debt obligations.
- High Short Interest and Days to Cover: Elevated short interest and a high days to cover ratio suggest significant market skepticism and a potential for extreme volatility due to short squeezes.
ECHO at a glance
| Market value | $31.8B |
| Revenue growth (year over year) | -5.2% |
| Profit margin | -38.8% |
| Debt / equity | 1.13 |
Frequently asked questions
Is ECHO a buy? In its research of November 3, 2026, TradeFlare's AI rated ECHO a HOLD. This is AI-generated research, not financial advice.
When was this analysis last updated? November 3, 2026. Stocks on TradeFlare's lists are re-researched every market night. How the research works.
Research of November 3, 2026 · AI-generated analysis for educational purposes, can be wrong, not financial advice.